Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Viridian Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
225
0 vs. Q4 2025
Shares held
112.4M
+10.3M (+10.1%) vs. Q4 2025
Total value
$2.21B
−$963.9M (−30.3%) vs. Q4 2025
New holders
49
80 more added
Sold out
49
67 more reduced

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 225 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ1 2026: $2.21B
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding VRDN in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC15,379,377$300.8M0.02%+994,921+6.9%Added
BlackRock, Inc.7,831,475$153.2M0.00%+1,399,552+21.8%Added
Bellevue Group AG6,726,144$131.6M3.13%+2,367,617+54.3%Added
State Street Corp4,672,885$91.4M0.00%+1,206,325+34.8%Added
Vanguard Capital Management LLC4,167,201$81.5M0.00%+4,167,201New
Fairmount Funds Management LLC3,914,458$76.6M5.53%00.0%Unchanged
VR Adviser, LLC3,882,709$75.9M2.83%00.0%Unchanged
Price T Rowe Associates Inc3,206,035$62.7M0.01%−233,379−6.8%Reduced
Paradigm Biocapital Advisors LP3,148,893$61.6M1.26%+1,705,791+118.2%Added
Wellington Management Group LLP3,078,554$60.2M0.01%+1,107,143+56.2%Added
Kynam Capital Management, LP2,341,652$45.8M2.91%+871,111+59.2%Added
Geode Capital Management, LLC2,333,213$45.6M0.00%+341,039+17.1%Added
Citadel Advisors LLC2,318,234$45.3M0.03%+1,638,540+241.1%Added
Balyasny Asset Management LLC2,315,957$45.3M0.09%+1,812,089+359.6%Added
Alliancebernstein L.P.1,392,072$43.3M0.01%−22,109−1.6%Reduced
Novo Holdings A/S2,000,000$39.1M3.17%−380,000−16.0%Reduced
Baker Bros. Advisors LP1,971,678$38.6M0.22%00.0%Unchanged
Tang Capital Management LLC1,792,626$35.1M1.78%00.0%Unchanged
Fisher Asset Management, LLC1,768,295$34.6M0.01%−11,989−0.7%Reduced
Vanguard Portfolio Management LLC1,641,477$32.1M0.00%+1,641,477New
Goldman Sachs Group Inc1,591,945$31.1M0.00%+327,898+25.9%Added
Avoro Capital Advisors LLC1,500,000$29.3M0.29%00.0%Unchanged
Deep Track Capital, LP1,393,944$27.3M0.56%−1,130,889−44.8%Reduced
D. E. Shaw & Co., Inc.1,262,540$24.7M0.02%+261,823+26.2%Added
Perceptive Advisors LLC1,170,829$22.9M0.45%−1,871,874−61.5%Reduced
Bank of America Corp1,163,615$22.8M0.00%+173,498+17.5%Added
Deutsche Bank AG1,032,316$20.2M0.01%+552,558+115.2%Added
JPMorgan Chase & Co1,059,864$19.6M0.00%+49,604+4.9%Added
Adage Capital Partners GP, L.L.C.970,018$19.0M0.03%+180,000+22.8%Added
Loomis Sayles & Co L P927,717$18.1M0.02%−553,418−37.4%Reduced
First Turn Management, LLC911,337$17.8M1.99%+220,809+32.0%Added
Rice Hall James & Associates, LLC898,611$17.6M0.98%+14,079+1.6%Added
UBS Asset Management Americas Inc888,298$17.4M0.00%+748,938+537.4%Added
Morgan Stanley870,162$17.0M0.00%−868,063−49.9%Reduced
Charles Schwab Investment Management Inc727,937$14.2M0.00%−21,024−2.8%Reduced
Eversept Partners, LP713,269$14.0M0.92%−1,068,966−60.0%Reduced
Candriam Luxembourg S.C.A.711,739$13.9M0.07%−73,359−9.3%Reduced
MetLife Investment Management708,527$13.9M0.07%+664,542+1,510.8%Added
Woodline Partners LP700,929$13.7M0.05%−415,000−37.2%Reduced
Northern Trust Corp696,999$13.6M0.00%+28,582+4.3%Added
Federated Hermes, Inc.668,968$13.1M0.02%+252,610+60.7%Added
MPM Oncology Impact Management LP649,873$12.7M0.98%+649,873New
Nuveen, LLC604,914$11.8M0.00%−137,423−18.5%Reduced
Vanguard Fiduciary Trust Co591,225$11.6M0.00%+591,225New
Algert Global LLC563,999$11.0M0.17%+138,960+32.7%Added
Parkman Healthcare Partners LLC557,936$10.9M1.13%−230,140−29.2%Reduced
Elmind Capital, LP534,931$10.5M2.97%−323,700−37.7%Reduced
Dimensional Fund Advisors LP529,763$10.4M0.00%−25,831−4.6%Reduced
ExodusPoint Capital Management, LP330,390$6.46M0.06%+237,693+256.4%Added
Point72 Asset Management, L.P.322,836$6.31M0.01%+68,551+27.0%Added
Pictet Asset Management Holding SA314,031$6.14M0.01%−608,736−66.0%Reduced
Panagora Asset Management Inc313,700$6.14M0.02%−11,046−3.4%Reduced
UBS Group AG307,134$6.01M0.00%+142,314+86.3%Added
ADAR1 Capital Management, LLC304,422$5.95M0.36%+227,224+294.3%Added
Davern Capital Partners, LP302,457$5.92M1.62%+40,842+15.6%Added
First Trust Advisors LP301,529$5.90M0.00%+181,637+151.5%Added
Raymond James Financial Inc293,308$5.45M0.00%−10,466−3.4%Reduced
Voleon Capital Management LP269,742$5.28M0.11%−75,971−22.0%Reduced
Marshall Wace, LLP269,587$5.27M0.01%−1,106,152−80.4%Reduced
BNP Paribas Arbitrage, SA266,399$5.21M0.00%−250,999−48.5%Reduced
Voya Investment Management LLC262,017$5.13M0.01%+248,256+1,804.1%Added
XTX Topco Ltd253,972$4.97M0.09%+206,939+440.0%Added
Rosalind Advisors, Inc.250,401$4.90M2.01%−199,599−44.4%Reduced
Affinity Asset Advisors, LLC250,000$4.89M0.29%00.0%Unchanged
Russell Investments Group, Ltd.234,551$4.59M0.00%+41,072+21.2%Added
Qube Research & Technologies Ltd231,270$4.52M0.01%+101,738+78.5%Added
Bank of New York Mellon Corp216,525$4.24M0.00%+659+0.3%Added
Propel Bio Management, LLC210,163$4.09M2.58%−72,368−25.6%Reduced
Yiheng Capital Management, L.P.208,735$4.08M1.77%00.0%Unchanged
Renaissance Technologies LLC203,100$3.97M0.01%+203,100New
Victory Capital Management Inc188,177$3.68M0.00%−38,640−17.0%Reduced
Knott David M Jr181,000$3.54M2.11%+36,000+24.8%Added
Hennion & Walsh Asset Management, Inc.174,894$3.42M0.12%+5,727+3.4%Added
Privium Fund Management B.V.173,516$3.39M0.71%00.0%Unchanged
Vivo Capital, LLC166,288$3.25M0.27%−816,288−83.1%Reduced
Frontier Capital Management Co LLC158,371$3.10M0.03%+158,371New
SEB Asset Management AB156,957$3.07M0.01%+156,957New
Invesco Ltd.152,596$2.98M0.00%−30,872−16.8%Reduced
Rafferty Asset Management, LLC141,977$2.78M0.01%+42,227+42.3%Added
Millennium Management LLC140,595$2.75M0.00%−319,530−69.4%Reduced
BNP PARIBAS ASSET MANAGEMENT Holding S.A.140,260$2.74M0.00%+139,364+15,554.0%Added
HighVista Strategies LLC134,229$2.63M0.72%−238,243−64.0%Reduced
Swiss National Bank128,600$2.52M0.00%00.0%Unchanged
KVP Capital Advisors, LP125,000$2.44M1.83%+125,000New
Nicholas Investment Partners, LP124,257$2.43M0.18%+57,175+85.2%Added
Barclays PLC100,598$1.97M0.00%−143,675−58.8%Reduced
Rhumbline Advisers100,033$1.96M0.00%+2,582+2.6%Added
Moody Aldrich Partners LLC95,235$1.86M0.34%−952−1.0%Reduced
Merck & Co., Inc.93,414$1.83M0.52%00.0%Unchanged
Wells Fargo & Company93,204$1.82M0.00%−54,112−36.7%Reduced
Velan Capital Investment Management LP91,123$1.78M1.12%+4,623+5.3%Added
Nomura Asset Management International Inc.85,390$1.67M0.00%−69,349−44.8%Reduced
Manufacturers Life Insurance Company, The81,425$1.59M0.00%−31,257−27.7%Reduced
California State Teachers Retirement System81,021$1.58M0.00%+17,724+28.0%Added
Twinbeech Capital LP76,884$1.50M0.16%+29,203+61.2%Added
Principal Financial Group Inc75,200$1.47M0.00%−100,730−57.3%Reduced
J. Safra Sarasin Holding AG73,058$1.43M0.02%−15,213−17.2%Reduced
State of Wisconsin Investment Board70,244$1.37M0.00%+2,450+3.6%Added
Fideuram - Intesa Sanpaolo Private Banking S.P.A.69,530$1.36M0.05%+6,801+10.8%Added
Aquatic Capital Management LLC68,461$1.34M0.04%+43,997+179.8%Added